Post-approval studies (Phase 4)UnknownNCT03274284What this trial is testingChemoradiotherapy for Recurrent T1G3 Bladder CancerWho this might be right forBladder Cancer Assiut University 20
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableStudy completedNCT00303654What this trial is testingLoop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral ResectionWho this might be right forBladder Cancer Roei Medical Technologies Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03914794What this trial is testingPemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsWho this might be right forBladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT01090466What this trial is testingGemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Cardiff University 15
Not applicableNo Longer AvailableNCT03801278What this trial is testingAn Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder CancerWho this might be right forRecurrent Bladder Cancer Five Prime Therapeutics, Inc.
Not applicableStudy completedNCT04723121What this trial is testingCan We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological MarkersWho this might be right forBladder Cancer Mansoura University 204
Large-scale testing (Phase 3)Study completedNCT00445601What this trial is testingS0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 406
Not applicableStudy completedNCT02700464What this trial is testingThe Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell CarcinomaWho this might be right forBladder Cancer Nucleix Ltd. 680
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032What this trial is testingEfficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)Who this might be right forHigh-risk Non-muscle Invasive Bladder Cancer Merck Sharp & Dohme LLC 1,397
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Not applicableUnknownNCT05176145What this trial is testingDemonstration of the Medical Interest of the VisioCyt® Artificial Intelligence TestWho this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) Vitadx 400
Testing effectiveness (Phase 2)WithdrawnNCT02718742What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder CancerWho this might be right forRecurrent Bladder Urothelial CarcinomaStage IV Bladder Urothelial Carcinoma Mayo Clinic
Very early researchStudy completedNCT00734994What this trial is testingMitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder CancerWho this might be right forTransitional Cell Carcinoma of BladderSuperficial Bladder Cancer Mark Dewhirst 15
Large-scale testing (Phase 3)Looking for participantsNCT06241755What this trial is testingClinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-Muscle Invasive Bladder Cancer Chengdu CoenBiotech Co., Ltd 412
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03125460What this trial is testingClinical Evaluation of a Test for Monitoring the Recurrence of Bladder CancerWho this might be right forBladder Cancer Cepheid 424
Testing effectiveness (Phase 2)Study completedNCT01821105What this trial is testing2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal CancerWho this might be right forRecurrent Colon CancerRecurrent Rectal CancerStage IV A Bladder Cancer+3 more Ohio State University Comprehensive Cancer Center 21
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT01675219What this trial is testingFluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)Who this might be right forBladder Cancer Turku University Hospital 400